TABLE 4.
SNP | Position | Allele (major/minor) | MAF (case/control) | p | OR (95%CI) | Mapped gene | Previous study | Previous study phenotype |
---|---|---|---|---|---|---|---|---|
rs1291122587 | 9:133270497 | GA/G | 0.26/0.59 | 7.02E-18 | 0.24 (0.18–0.34) | Intron of ABO | HGI | Hospitalized covid vs. population |
Hospitalized covid vs. population, leave out 23 and Me (EUR) | ||||||||
Covid vs. population | ||||||||
Covid vs. population, leave out 23 and Me (EUR) | ||||||||
rs8111981 | 19:977763 | G/A | 0.28/0.35 | 3.37E-02 | 0.70 (0.50–0.97) | Downstream of ARID3A | HGI | Very severe respiratory confirmed covid vs. population |
rs9975538 | 21:33254549 | C/T | 0.29/0.37 | 4.37E-02 | 0.71 (0.52–0.98) | Intron of IFNAR2 | HGI | Very severe respiratory confirmed covid vs. population |
Hospitalized covid vs. population | ||||||||
Hospitalized covid vs. population, leave out 23 and Me (EUR) | ||||||||
rs429358 | 19:44908684 | T/C | 0.11/0 | 4.29E-14 | NA | Missense of APOE | PMID: 32451547 | Positive COVID-19 patients vs. participants negative or not tested |
rs10734222 | 11:14244913 | G/A | 0.17/0.24 | 1.19E-02 | 0.61 (0.42–0.90) | Intron of SPON1 | HGI | Hospitalized covid vs. population, leave out 23 and Me (EUR) |
rs59492037 | 6:4571951 | A/G | 0.27/0.35 | 2.63E-02 | 0.68 (0.49–0.95) | Intron of AL162718.1 | HGI | Very severe respiratory confirmed covid vs. not hospitalized covid |
rs4302292 | 21:33919239 | G/A | 0.31/0.23 | 3.07E-02 | 1.47 (1.05–2.05) | Upstream of ATP5PO | HGI | Covid vs. population |
rs71327056 | 3:46348485 | C/G | 0.01/0.04 | 3.12E-02 | 0.27 (0.08–0.92) | Intergenic of UQCRC2P1-CCR2 | HGI | Very severe respiratory confirmed covid vs. population |
Hospitalized covid vs. population | ||||||||
Hospitalized covid vs. population, leave out 23 and Me (EUR) | ||||||||
rs1886814 | 6:41534945 | A/C | 0.45/0.37 | 3.60E-02 | 1.39 (1.03–1.88) | Intron of FOXP4-AS1 | HGI | Hospitalized covid vs. population |